De novo variants in SUPT16H cause neurodevelopmental disorders associated with corpus callosum abnormalities

Roya Bina, Dena Matalon, Brieana Fregeau, Jacqueline Joani Tarsitano, Ingvild Aukrust, Gunnar Houge, Renee Bend, Hannah Warren, Roger E Stevenson, Kyra Eva Stuurman, A James Barkovich, Elliott H Sherr, Roya Bina, Dena Matalon, Brieana Fregeau, Jacqueline Joani Tarsitano, Ingvild Aukrust, Gunnar Houge, Renee Bend, Hannah Warren, Roger E Stevenson, Kyra Eva Stuurman, A James Barkovich, Elliott H Sherr

Abstract

Introduction: Whole-exome sequencing (WES) has identified de novo variants in chromatin remodelling genes in patients with neurodevelopmental disorders (NDD). We report on a novel genetic discovery in chromatin remodelling in patients with NDD who also have corpus callosum (CC) anomalies.

Objective: To discover novel genes linked to both CC anomalies and NDD.

Methods: Clinical WES was performed for evaluation of NDD, identifying five patients with de novo variants in SUPT16H, a subunit of the FACT (facilitates chromatin transcription) complex. The clinical phenotypes, genetic results and brain MRIs were obtained and systematically reviewed. In silico protein function predictions were assessed and allele frequencies in control populations were compared.

Results: We identified four patients with de novo missense variants in SUPT16H and one patient with a de novo deletion including SUPT16H. These variants were not reported in the updated Genome Aggregation Database. When assayable, all protein products were predicted to be damaging. Symptoms included intellectual disability, autistic features, minor dysmorphic features and seizures. Anomalies of the CC were seen in all three patients with available brain imaging.

Conclusion: Our findings implicate the gene SUPT16H in a novel disorder characterised by neurodevelopmental deficits and CC anomalies.

Keywords: developmental; genetics; other neurology.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Molecular and clinical findings in patients with SUPT16H mutations. (A) A schematic model of the FACT complex interacting with the nucleosome. (B) Diagram of Spt16 protein indicating the location of principal domains and the variants identified. The mutations are grouped according to their locations on Spt16 domains. (C) Callosal abnormalities in selected patients with SUPT16H changes: (a) T1-weighted sagittal and coronal images demonstrating a thin corpus callosum and diminished white matter volume in patient 1; (b) T1-weighted sagittal and coronal images demonstrating a thin corpus callosum and enlarged lateral ventricles in patient 4; (c) T1 sagittal and T2 FLAIR coronal images demonstrating partial agenesis of the corpus callosum in patient 5. FACT, facilitates chromatin transcription; FLAIR, fluid-attenuated inversion recovery.

Source: PubMed

3
Se inscrever